LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Contributions to Research and Practice Made by the National Cancer Institute's Health Communication and Informatics Research Branch.

    Vanderpool, Robin C / Blake, Kelly D / Chou, Wen-Ying Sylvia / D'Angelo, Heather / Everson, Nicole Senft / Iles, Irina A / Gaysynsky, Anna

    Health communication

    2024  , Page(s) 1–8

    Abstract: The Health Communication and Informatics Research Branch at the U.S. National Cancer Institute was founded in 1999 in response to increasing evidence demonstrating a link between effective health communication and improved cancer-related outcomes and in ... ...

    Abstract The Health Communication and Informatics Research Branch at the U.S. National Cancer Institute was founded in 1999 in response to increasing evidence demonstrating a link between effective health communication and improved cancer-related outcomes and in recognition of the rapid and dramatic technological changes that were transforming health communication at the turn of the 21st century. For the past 25 years, the Health Communication and Informatics Research Branch has been conducting and supporting research at the forefront of emerging cancer communication trends and technologies, making numerous contributions to health communication science, public health, and cancer control practice. In this essay, we provide a brief history of the branch and the context that led to its establishment, discuss contributions made by the branch to health communication research and practice through key projects and initiatives, and conclude by highlighting health communication and informatics research priorities that offer opportunities for significant impact going forward in light of the challenges posed by the current communication environment.
    Language English
    Publishing date 2024-03-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1038723-7
    ISSN 1532-7027 ; 1041-0236
    ISSN (online) 1532-7027
    ISSN 1041-0236
    DOI 10.1080/10410236.2024.2326263
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Influence of Cost-Related Considerations on Clinical Trial Participation: Results from the 2020 Health Information National Trends Survey (HINTS).

    Williams, Courtney P / Geiger, Ann M / Norton, Wynne E / de Moor, Janet S / Everson, Nicole Senft

    Journal of general internal medicine

    2022  Volume 38, Issue 5, Page(s) 1200–1206

    Abstract: Background: People experiencing financial burden are underrepresented in clinical trials.: Objective: Describe the prevalence of cost-related considerations influential to trial participation and their associations with person-level characteristics.!# ...

    Abstract Background: People experiencing financial burden are underrepresented in clinical trials.
    Objective: Describe the prevalence of cost-related considerations influential to trial participation and their associations with person-level characteristics.
    Design: This cross-sectional study used and assessed how three cost-related considerations would influence the decision to participate in a hypothetical clinical trial.
    Participants: A total of 3682 US adult respondents to the Health Information National Trends Survey MAIN MEASURES: Survey-weighted multivariable logistic regression estimated associations between respondent characteristics and odds of reporting cost-related considerations as very influential to participation.
    Key results: Among 3682 respondents, median age was 48 (IQR 33-61). Most were non-Hispanic White (60%), living comfortably or getting by on their income (74%), with ≥ 1 medical condition (61%). Over half (55%) of respondents reported at least one cost-related consideration as very influential to trial participation, including if usual care was not covered by insurance (reported by 42%), payment for participation (24%), or support for participation (24%). Respondents who were younger (18-34 vs. ≥ 75, adjusted odds ratio [aOR] 4.3, 95% CI 2.3-8.1), more educated (high school vs. <high school, aOR 2.1, 95% CI 1.1-4.1), or with lower perceived income (having difficulty vs. living comfortably, aOR 2.1, 95% CI 1.1-3.8) had higher odds of reporting any cost-related consideration as very influential to trial participation. Non-Hispanic Black vs. non-Hispanic White respondents had 29% lower odds (95% CI 0.5-0.9) of reporting any cost-related consideration as very influential to trial participation.<br />Conclusions: Cost-related considerations would influence many individuals' decisions to participate in a clinical trial, though prevalence of these concerns differed by respondent characteristics. Reducing financial barriers to trial participation may promote equitable trial access and greater trial enrollment diversity.
    MeSH term(s) Adult ; Humans ; Middle Aged ; Cross-Sectional Studies ; Surveys and Questionnaires ; Income
    Language English
    Publishing date 2022-11-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-022-07801-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Quality of Medication Cost Conversations and Interest in Future Cost Conversations Among Older Adults.

    Everson, Jordan / Besaw, Robert J / Whitmore, Christine C / Joseph Mattingly, T / Sinaiko, Anna D / Keating, Nancy L / Everson, Nicole Senft / Dusetzina, Stacie B

    Journal of general internal medicine

    2023  Volume 38, Issue 16, Page(s) 3482–3489

    Abstract: Background: Medication cost conversations occur less frequently than patients prefer, and it is unclear whether patients have positive experiences with them when they do occur.: Objective: To describe patients' experiences discussing their medication ...

    Abstract Background: Medication cost conversations occur less frequently than patients prefer, and it is unclear whether patients have positive experiences with them when they do occur.
    Objective: To describe patients' experiences discussing their medication costs with their health care team.
    Design: Cross-sectional survey.
    Setting: Nationally representative survey fielded in the United States in 2022 (response rate = 48.5%).
    Patients: 1020 adults over age 65.
    Measurements: Primary measures were adapted from Clinician and Group Consumer Assessment of Healthcare Providers Survey visit survey v4.0 and captured patients' experiences of medication cost conversations. Additional measures captured patients' interest in future cost conversations, the type of clinicians with whom they would be comfortable discussing costs, and sociodemographic characteristics.
    Results: Among 1020 respondents who discussed medication prices with their health care team, 39.3% were 75 or older and 78.6% were non-Hispanic White. Forty-three percent of respondents indicated that their prior medication cost conversation was not easy to understand; 3% indicated their health care team was not respectful and 26% indicated their health care team was somewhat respectful during their last conversation; 48% indicated that there was not enough time. Those reporting that their prior discussion was not easy to understand or that their clinician was not definitely respectful were less likely to be interested in future discussions. Only 6% and 10% of respondents indicated being comfortable discussing medication prices with financial counselors or social workers, respectively. Few differences in responses were observed by survey participant characteristics.
    Limitations: This cross-sectional survey of prior experiences may be subject to recall bias.
    Conclusion: Among older adults who engaged in prior medication cost conversations, many report that these conversations are not easy to understand and that almost one-third of clinicians were somewhat or not respectful. Efforts to increase the frequency of medication cost conversations should consider parallel interventions to ensure the discussions are effective at informing prescribing decisions and reducing cost-related medication nonadherence.
    MeSH term(s) Humans ; United States ; Aged ; Cross-Sectional Studies ; Physician-Patient Relations ; Medication Adherence ; Surveys and Questionnaires ; Health Care Surveys
    Language English
    Publishing date 2023-09-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-023-08388-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Understanding Associations of Personal Values With Support for Tobacco and Alcohol Control Policies.

    Heley, Kathryn / D'Angelo, Heather / Oh, April / Vanderpool, Robin C / McQueen, Amy / Kreuter, Matthew W / Everson, Nicole Senft

    American journal of preventive medicine

    2023  Volume 65, Issue 3, Page(s) 448–457

    Abstract: Introduction: This cross-sectional analysis of the 2020 Health Information National Trends Survey (N=3,604) examines the associations of personal values with tobacco and alcohol control policy support, which may inform policy-related communication ... ...

    Abstract Introduction: This cross-sectional analysis of the 2020 Health Information National Trends Survey (N=3,604) examines the associations of personal values with tobacco and alcohol control policy support, which may inform policy-related communication efforts.
    Methods: Respondents selected which of 7 value options they considered most important in their daily life and rated their support for 8 proposed tobacco and alcohol control policies (1=strongly oppose, 5=strongly support). Weighted proportions for each value were described across sociodemographic characteristics, smoking status, and alcohol use. Weighted bivariate and multivariable regressions tested the associations of values with mean policy support (alpha=0.89). Analyses occurred from 2021 to 2022.
    Results: The most frequently selected values were assuring my family is safe and secure (30.2%), being happy (21.1%), and making my own decisions (13.6%). Selected values varied across sociodemographic and behavioral characteristics. For example, people with lower education and incomes were overrepresented among those selecting making my own decisions and keeping myself in good health. After adjusting for sociodemographics, smoking, and alcohol use, people selecting family safety (β=0.20, 95% CI=0.06, 0.33) or religious connection (β=0.34, 95% CI=0.14, 0.54) as most important reported higher policy support than those selecting making their own decisions, the value associated with the lowest mean policy support. Mean policy support did not significantly differ across any other value comparisons.
    Conclusions: Personal values are associated with support for alcohol and tobacco control policies, with making my own decisions associated with the lowest policy support. Future research and communication efforts may consider aligning tobacco and alcohol control policies with the idea of supporting autonomy.
    MeSH term(s) Humans ; Cross-Sectional Studies ; Smoking/epidemiology ; Public Policy ; Alcohol Drinking/prevention & control
    Language English
    Publishing date 2023-03-17
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 632646-8
    ISSN 1873-2607 ; 0749-3797
    ISSN (online) 1873-2607
    ISSN 0749-3797
    DOI 10.1016/j.amepre.2023.03.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top